Preparation and pharmacokinetic evaluation of curcumin solid dispersion using Solutol® HS15 as a carrier.

[1]  K. Järvinen,et al.  Intraorally fast-dissolving particles of a poorly soluble drug: preparation and in vitro characterization. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  Tak W. Kee,et al.  Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[3]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[4]  M. Másson,et al.  Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. , 2007, International journal of pharmaceutics.

[5]  Géza Horváth,et al.  Bioavailability enhancement of an active substance by supercritical antisolvent precipitation , 2007 .

[6]  G. Van den Mooter,et al.  Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. , 2006, International journal of pharmaceutics.

[7]  T. Baykara,et al.  Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. , 2005, Farmaco.

[8]  V. Keshamouni,et al.  Curcumin for malaria therapy. , 2005, Biochemical and biophysical research communications.

[9]  Anant Paradkar,et al.  Characterization of curcumin-PVP solid dispersion obtained by spray drying. , 2004, International journal of pharmaceutics.

[10]  S. Ozkan,et al.  Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  H. Tønnesen.  Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIII. , 2002, Die Pharmazie.

[12]  D. Craig,et al.  The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.

[13]  M. Khan,et al.  Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. , 2001, International journal of pharmaceutics.

[14]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[15]  N. Venkatesan,et al.  Curcumin prevents adriamycin nephrotoxicity in rats , 2000, British journal of pharmacology.

[16]  M. Majeed,et al.  Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. , 1998, Planta medica.

[17]  Lynne S. Taylor,et al.  Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions , 1997, Pharmaceutical Research.

[18]  Jen-kun Lin,et al.  Stability of curcumin in buffer solutions and characterization of its degradation products. , 1997, Journal of pharmaceutical and biomedical analysis.

[19]  V. Tantishaiyakul,et al.  Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. , 1996, International journal of pharmaceutics.

[20]  R. Puvanakrishnan,et al.  Protective role of curcumin against isoproterenol induced myocardial infarction in rats , 1996, Molecular and Cellular Biochemistry.

[21]  R. Kuttan,et al.  Potential anticancer activity of turmeric (Curcuma longa). , 1985, Cancer letters.

[22]  M. Dikshit,et al.  Anti-thrombotic effect of curcumin. , 1985, Thrombosis research.

[23]  H. Tønnesen,et al.  Studies on curcumin and curcuminoids , 1985, Zeitschrift fur Lebensmittel-Untersuchung und -Forschung.

[24]  Y. Oshima,et al.  Antihepatotoxic Principles of Curcuma longa Rhizomes1 , 1983, Planta medica.

[25]  S. Deodhar,et al.  Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). , 1980, The Indian journal of medical research.

[26]  R. Srimal,et al.  Pharmacology of diferuloyl methane (curcumin), a non‐steroidal anti‐inflammatory agent * , 1973, The Journal of pharmacy and pharmacology.

[27]  K. Srinivasan,et al.  Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats , 2004, Molecular and Cellular Biochemistry.

[28]  H. P. Ramesh,et al.  Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guineapigs & monkeys. , 1980, Indian journal of experimental biology.